These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2109524)

  • 21. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
    Fornaro G; Lazzero M; Giacalone A; Aralda D; Prando MD; Rossi L; Bongo AS
    G Ital Cardiol (Rome); 2008 Jun; 9(6):408-20. PubMed ID: 18681392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-Reteplase Evaluation of Clinical Safety & Efficacy in Indian Patients (Precise-In Study).
    Singh RK; Trailokya A; Naik MM
    J Assoc Physicians India; 2015 Apr; 63(4):30, 32-5. PubMed ID: 26591167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI).
    Di Mario C; Bolognese L; Maillard L; Dudek D; Gambarati G; Manari A; Guiducci V; Patrizi G; Rusconi LC; Piovaccari G; Hibon AR; Belpomme V; Indolfi C; Olivari Z; Steffenino G; Zmudka K; Airoldi F; Panzarasa R; Flather M; Steg PG
    Am Heart J; 2004 Sep; 148(3):378-85. PubMed ID: 15389222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the clinical efficacy of recombinant tissue-type plasminogen activator thrombolysis with primary coronary stenting in acute myocardial infarction].
    Chen B; Wang W; Zhao H; Zhao M; Hubayi ; Xu CD; Lu M
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):21-3. PubMed ID: 11940291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial.
    Gibson CM; Cannon CP; Greene RM; Sequeira RF; Margorien RD; Leya F; Diver DJ; Baim DS; Braunwald E
    Am J Cardiol; 1997 Jul; 80(1):21-6. PubMed ID: 9205014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?
    Kloner RA; Alker K; Campbell C; Figures G; Eisenhauer A; Hale S
    Circulation; 1989 May; 79(5):1125-36. PubMed ID: 2496937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators.
    Chaitman BR; Thompson B; Wittry MD; Stump D; Hamilton WP; Hillis LD; Dwyer JG; Solomon RE; Knatterud GL
    J Am Coll Cardiol; 1989 Nov; 14(5):1159-65. PubMed ID: 2509528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart rupture in acute myocardial infarct: the advantages of using M-2D color Doppler echocardiography in a coronary intensive therapy unit].
    Perrone C; Pasquetto G; Boschello M; Dovigo P; Marchiori MC; Galassi A; De Dominicis E
    G Ital Cardiol; 1999 Jun; 29(6):662-8. PubMed ID: 10396670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.
    Holmes DR; Califf RM; Van de Werf F; Berger PB; Bates ER; Simoons ML; White HD; Thompson TD; Topol EJ
    Lancet; 1997 Jan; 349(9045):75-8. PubMed ID: 8996417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study.
    Becker RC; Charlesworth A; Wilcox RG; Hampton J; Skene A; Gore JM; Topol EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1063-8. PubMed ID: 7897117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short-term results of rescue angioplasty in patients with acute myocardial infarction and failure of thrombolysis treatment].
    Palomo Villada JA; Santiago Hernández JA; González Díaz B; Astudillo Sandoval R; Flores Flores J; Montoya Silvestre A; Estrada Gallegos J; Bernal Ruiz E; Farell Campa J
    Arch Cardiol Mex; 2005; 75(3):296-305. PubMed ID: 16294818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year follow-up after recombinant tissue plasminogen activator administered to patients with acute myocardial infarction.
    McNeill AJ; Dickey W; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Eur Heart J; 1991 May; 12(5):624-9. PubMed ID: 1908384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of cardiogenic shock in acute myocardial infarct].
    Görge G; Haude M; Baumgart D; Sack S; Ge J; Leischik R; Erbel R
    Herz; 1994 Dec; 19(6):360-70. PubMed ID: 7843692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators.
    Chaitman BR; Thompson BW; Kern MJ; Vandormael MG; Cohen MB; Ruocco NA; Solomon RE; Braunwald E
    Am Heart J; 1990 Feb; 119(2 Pt 1):213-23. PubMed ID: 2105625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
    Rogers WJ; Bourge RC; Papapietro SE; Wackers FJ; Zaret BL; Forman S; Dodge HT; Robertson TL; Passamani ER; Braunwald E
    Am J Cardiol; 1989 Mar; 63(9):503-12. PubMed ID: 2521976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.